Therapeutic insights into arterial ageing: PCBP2 inhibits Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins via down regulation of its target gene 08/February/2015, 14.30

Therapeutic insights into arterial ageing: PCBP2 inhibits Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins via down regulation of its target gene 08/February/2015, 14.30

Therapeutic insights into arterial ageing: PCBP2 inhibits Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins via down regulation of its target gene 08/February/2015, 14.30 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Therapeutic insights into arterial ageing: PCBP2 inhibits Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins via down regulation of its target gene 08/February/2015, 14.30, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests that PCBP2, by decreasing the expression of its target gene, it may inhibit Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins.  Thereby, it may inhibit arterial ageing and ageing associated-cardiovascular diseasesThus, this study suggests that pharmacological formulations encompassing PCBP2 or its activators may be used to prevent arterial ageing.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How PCBP2  inhibits Vascular Smooth Muscle Cells Senescence and the expression of senescence-associated pro-inflammatory proteins

Amount: $300*